LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
13.49
-0.03 (-0.22%)
At close: Feb 27, 2026, 4:00 PM EST
13.23
-0.26 (-1.93%)
After-hours: Feb 27, 2026, 7:53 PM EST
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $422.10 million as of February 27, 2026. Its market cap has decreased by -38.21% in one year.
Market Cap
422.10M
Enterprise Value
220.88M
1-Year Change
-38.21%
Ranking
Category
Stock Price
$13.49
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has increased from $413.64M to $422.10M, an increase of 2.04%. That is a compound annual growth rate of 1.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 422.10M | -15.69% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 442.95M |
| Verastem | 441.48M |
| DiaMedica Therapeutics | 440.95M |
| PepGen | 428.99M |
| Upstream Bio | 426.90M |
| Absci | 422.54M |
| Enanta Pharmaceuticals | 418.17M |
| Niagen Bioscience | 414.86M |